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 Introduction 
 As the Belmont Report cautioned in 1979, the poor and minorities 
may be overrepresented in clinical research because their social 
status potentially leaves them vulnerable to manipulation. 1 Today, 
with empiric evidence of underenrollment of minorities in clinical 
research, NIH guidelines require “appropriate representation” 
of minorities to achieve the goals of equitable distribution 
of beneﬁ ts and burdens of research and identify if there are 
possible diﬀ erences in treatment by race/ethnicity. 2,3 Increasing 
representation of minorities in clinical trials is intended to 
best serve their health needs by ensuring accurate data about 
response to interventions. While persistent underrepresentation 
of minorities has been well described, 4,5 reasons for their under-
representation are less clear. 
 One possible explanation is that minorities may expect 
diﬀ erent amounts of payment for participation in clinical research 
than others in society. No research has utilized a nationally 
representative sample of the public to determine the extent 
to which expectations of payment may aﬀ ect participation of 
diﬀ erent racial/ethnic groups. 6–10 Given that up to one-third of 
studies do not meet enrollment goals, 11 it is important to determine 
the potential role payment plays in that underenrollment. 
 Additionally, there are persistent theoretical concerns that 
the burdens of clinical research may be disproportionately 
experienced by the poor, 1,12 particularly because they will be 
unduly inﬂ uenced to participate by even modest payments and 
overlook signiﬁ cant risk. 13,14 IRB members are sensitive to these 
concerns; 15 46% of IRB participants acknowledge that their IRB 
panel sometimes questions the amount of proposed payment to 
participants. 16 However, the distribution of research participation 
by income group is not reliably known because many clinical 
trials do not collect socioeconomic information on participants. 
 Th e ﬁ rst goal of this study was to examine how previous 
participation in research is distributed across diﬀ erent household 
income groups and racial/ethnic groups. Th e second goal of this 
study was to assess how the public perceives what is fair payment 
for a low-risk clinical trial and whether there is an association 
between the amount of payment requested for research 
participation and sociodemographic characteristics of individuals. 
Using these ﬁ ndings, the third goal was to estimate the amount of 
payment that would be necessary for a hypothetical medication 
trial to achieve proportional representation of minorities and 
individuals from diﬀ erent socioeconomic groups. 
 Methods 
 Study sample 
 Th is is a cross-sectional study with data collected in 2011 by the 
C.S. Mott Children’s Hospital National Poll on Children’s Health 
(NPCH), a Web-based survey distributed by Knowledge Networks 
using a Web-enabled KnowledgePanel. 17 Th e KnowledgePanel is 
assembled using rigorous address-based sampling and random-
digit dialing techniques and provides free computer hardware 
and Internet access for all contacted households that wish to 
participate. Participants received payment for participation in 
the survey. Th e KnowledgePanel has served as a sampling frame 
for multiple peer-reviewed publications that have assessed public 
perceptions and opinions at the national level. 18–22 
 This study sample included 2,150 adults nationally 
representative of the United States. Demographic information 
(age, sex, race/ethnicity, household income, and health conditions), 
previous research participation, distance to a research center 
and responses to hypothetical scenarios were provided by 
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respondents. Race/ethnicity was categorized as non-Hispanic 
white, non-Hispanic black, other non-Hispanic and Hispanic. 
Yearly household income was categorized as <$30,000; $30–
60,000; $60–100,000; and >$100,000. A complex survey design 
was used to achieve a nationally representative sample of adults 
as determined by the 2010 Current Population Survey (CPS). 
 Survey instrument 
 Th e primary survey questions used for our analysis probed 
respondents’ perceptions of a fair amount of payment paid as a 
“thank you” for participation in research (Appendix Figure A1). 
Respondents were presented a scenario describing participation as 
a volunteer in a low-risk medication trial that would require daily 
medication for 2 months, then no medication during 10 months of 
follow-up, and medical evaluation requiring two blood draws and 
one physical exam. Respondents were asked to indicate the “total 
payment you believe is fair for an adult to receive as a thankyou 
for participating;” they were told that all transportation costs 
would be reimbursed separate from the payment. Th ere were no 
anchors provided and respondents could enter a number ranging 
from $0 to $10,000. We recognize that respondents could interpret 
the question as requesting their participation as either a healthy 
volunteer or if they had the disease being studied. 
 Additional survey questions probed the importance of 
diﬀ erent factors in respondents’ willingness to participate in 
research as a healthy volunteer or if the respondent had the 
disease being studied. To minimize respondent burden, sets of 
questions were randomly presented so that not all questions were 
given to all respondents. Respondents were asked to indicate 
how important (very, somewhat, or not important) each of the 
following factors would be when considering whether they would 
participate in medical research: total amount of time required 
to participate; amount of pain/discomfort; risks of the research 
study; inconvenience or “hassle”; amount of payment or incentive 
for participating; beneﬁ ts of research for one’s own health; beneﬁ ts 
of research for the health of others. In addition, a separate survey 
question asked that if respondents wanted to participate in 
medical research how far would they have to travel (categorized 
as 15 minutes or less; 15–30 minutes; 31–60 minutes; >60 minutes; 
unsure of where nearest medical research site is located). Finally, 
participants were asked, “have you ever participated in any type 
of medical research?” 
 Analyses of interest 
 Th e ﬁ rst analysis of interest included demographic information 
(race/ethnicity and yearly household income) associated with 
previous participation in research. Th e second analysis focused 
on the amount of payment perceived to be fair for a low-risk 
medication trial, to investigate if there were diﬀ erences across 
racial/ethnic and income groups. Th e third analysis centered on 
the amount of payment necessary for the hypothetical medication 
trial to achieve proportional representation of minorities and 
individuals from diﬀ erent socioeconomic groups. 
 Missing data 
 Multiple imputation using chained equations was used to 
impute missing data for how important diﬀ erent factors were in 
determining whether someone would be willing to participate 
in medical research (e.g., total amount of time required to 
participate; amount of pain/discomfort; risks of the research 
study; inconvenience or “hassle”; amount of payment or incentive 
for participating; beneﬁ ts of research for one’s own health; beneﬁ ts 
of research for the health of others). Imputation was utilized for 
approximately 400 observations that were missing not at random 
due to our survey design intended to mitigate respondent burden. 
Imputations were calculated utilizing demographic information 
(sex, race/ethnicity, yearly household income) and responses to 
other questions including previous research participation and 
distance to research center. 
 Statistical analyses 
 First, to determine the distribution of research participation 
by race/ethnicity and income we used descriptive statistics to 
determine the percent of all respondents who participated in 
research over categories of race, ethnicity and income. We also 
used descriptive statistics to demonstrate the mean and median 
requested payment by racial/ethnic and income groups. Next, 
to determine the relationship between perceived fair payment 
and individual-level characteristics we used multivariable linear 
regression with requested payment as the dependent variable. 
Because data for requested payment was skewed to the right, we 
log-transformed the outcome. Independent variables included 
demographic characteristics (self-reported age, sex, and race/
ethnicity), annual household income, distance to travel to 
research center, and the importance of six diﬀ erent factors in the 
respondent’s willingness to participate in research (importance of 
time, hassle, pain, risk, beneﬁ t to self, beneﬁ t to others). Subjects 
who refused participation in both healthy and patient-based 
research (6% of the sample) were not included in the analysis. 
 Th e associations of race/ethnicity and income with requested 
payment were examined using regression coeﬃ  cients. Th ese 
coeﬃ  cients represent the percent diﬀ erence in requested payment 
for each category, because our outcome was log-transformed. 
 Finally, to estimate the amount of payment required to achieve 
proportional representation of minorities and low-income 
populations in our survey scenario, we varied the level of payment 
for research in $100 intervals and estimated the proportion of 
patients willing to participate at a given level of payment by 
summing the number of respondents believing a payment at 
that level or lower was fair payment until approximately 50% 
of respondents believed payment was fair. We then compared 
these racial/ethnic and household income distributions at each 
payment level to a nationally representative population of the 
United States using survey weighted proportions for those 
demographic characteristics as determined by the 2010 CPS. All 
analyses were performed using Stata, version 12.0 (StataCorp, 
College Station, TX, USA). 
 Results 
 Sample characteristics 
 Th e participation rate among those invited to answer the survey 
was 60%. Th e study sample included 2,150 participants, with 
nationally weighted demographic characteristics as shown in 
Table  1 . Eleven percent ( n = 221) of the sample had previously 
participated in medical research (Table  1 ). 
 Distribution of research participation by race/ethnicity and 
income 
 In our sample, individuals in minority racial/ethnic groups were 
signiﬁ cantly less likely to have participated in research than were 
non-Hispanic whites: 4% of Hispanics and 2% of non-Hispanic 
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blacks compared with 14% of whites ( p = 
0.001 and  p < 0.001, respectively). Th ere 
was comparatively less variation in prior 
participation by income (Table  2 ). 
 Requested payment for research 
participation 
 Across the full sample, the median requested 
payment for adults’ participation in the 
speciﬁ ed low-risk research study was $300, 
with a mean of $1,160 (range $0–$10,000). 
Among those willing or unsure if they would 
participate in research the median requested 
payment was $300 with a mean of $1,119. 
 Median requested payments were 
approximately one-third of the mean 
requested payments, but both median and 
means demonstrated similar trends that were 
also demonstrated in the multivariate linear 
regression. Requested payment differed 
signiﬁ cantly by annual household income. 
Aft er adjusting for respondent characteristics, 
distance to research center and stated 
importance of factors aﬀ ecting willingness 
to participate (Table  3 ), the $30,000–60,000 
income group was requesting less payment 
than the lowest income group (–0.36 [95% 
CI –0.69, –0.03]). We found no signiﬁ cant 
diﬀ erences in requested payment in higher 
income groups compared to the lowest 
income group. Unadjusted median and mean 
requested payment by income (Table   4 ) 
demonstrated a similar trend with lowest 
income group requesting median payment 
$400 with $30–60,000 requesting $300 and 
highest income group requesting $300. 
 Requested payment also different 
significantly by racial/ethnic group with 
Hispanics requesting more payment than 
non-Hispanic whites (0.37 [95%CI 0.02, 
0.72]) (Table   3 ). Unadjusted medians and 
means demonstrated the same trends with 
non-Hispanic whites requesting $300 while 
Hispanics requested $500 (Table  4 ). 
 Finally, respondents who indicated that beneﬁ ting others 
was not important to them in determining whether they would 
participate in research were more likely to request higher payment 
for participation (coeﬀ . 0.94; 95%CI 0.13, 1.86). 
 Estimated eﬀ ects on sample composition of varying levels of 
payment 
 We also estimated the overall population proportion and the relative 
proportions of diﬀ erent racial/ethnic and income groups that would 
believe payment for participation is fair at diﬀ erent payment levels 
in increments of $100. Th ese estimates permitted us to examine 
which level of payment would most closely approximate relative 
proportions of diﬀ erent racial/ethnic and income groups in the 
United States. For the diﬀ erent panels of Figures  1 and 2 representing 
proportions for different potential payment, the bars that are 
smaller and closer to the 0 baseline most closely are aligned with 
the representation of that group in the US population. 
 Frequency (unweighted 
proportion) 
Weighted proportion 
% (95% CI) 
Sex 
  Male 1,038 (48) 48 (45–52) 
  Female 1,112 (52) 52 (48–55) 
Age (in years) 
  18—29 393 (18) 19 (16–22) 
  30—44 845 (39) 28 (25–31) 
  45—59 679 (32) 29 (26–33) 
  >60 233 (11) 24 (21–28) 
Income (in dollars) 
  <$30K 542 (25) 34 (30–37) 
  $30–60K 651 (30) 31 (28–34) 
  $60–100K 610 (28) 23 (21–26) 
  >$100K 347 (16) 12 (10–14) 
Race/ethnicity 
  Non-Hispanic white 1,587 (74) 70 (67–73) 
  Non-Hispanic black 190 (9) 11 (9–13) 
  Non-Hispanic other 146 (7) 7 (5–9) 
  Hispanic 227 (11) 12 (10–15) 
  Previous research participation 221 (10) 11 (9–14) 
Distance to travel for participation 
  15 minutes or less 327 (15) 13 (11–16) 
  15–30 minutes 495 (23) 20 (18–23) 
  31–60 minutes 314 (15) 17 (14–20) 
  >60 minutes 128 (6) 7 (6–10) 
  Unsure of distance 871 (41) 42 (39–46) 
Willingness to participate in clinical research 
  Yes 1,070 (50) 47 (43–50) 
  Unsure 960 (45) 47 (44–50) 
  No 120 (6) 6 (5–8) 
 Table 1.  Demographics of NPCH from 2011. 
 Weighted proportion of each 
group who reported prior 
participation  n = 221% 
(95% CI) 
Race/ethnicity 
  Non-Hispanic white 14 (11–17) 
  Non-Hispanic black 2 (0.8–6) 
  Non-Hispanic other 14 (6–30) 
  Hispanic 4 (2–8) 
Annual household income 
  <$30,000 13 (9–18) 
  $30,000–$60,000 10 (7–15) 
  $60,001–$100,000 10 (7–15) 
  >$100,000 14 (9–21) 
 Table 2.  Proportion of previous research participants by race/ethnicity and income. 
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 Overall, increasing payment from $49 to $349 for the same 
low-risk medical research would be expected to increase those 
believing payment was fair from 7% to 50%. For each cohort at the 
diﬀ erent payment levels, the relative proportion of an individual 
group shift s depending on what proportion of the overall whole 
they comprise. 
 For underrepresented racial/ethnic minority groups, payment 
at $349 yielded the closest overall match in perceived fairness 
when compared with population representation for adults 
(Figure 1). At lower levels of payment, non-Hispanic whites 
were consistently overrepresented in believing payment was fair 
and Hispanics and non-Hispanic blacks were typically under-
represented, compared with Census distributions of those racial/
ethnic groups. At payment levels above $349, proportions of 
participants’ perceptions of fairness remained matched to census 
distributions of racial/ethnic groups. 
 When examining relative proportional representation in 
research for diﬀ erent income groups related to perceived fairness 
 Coeffi cient 95% Confi dence interval 
Sex (reference: female) 
 Male 0.10 –0.15, +0.36 
Race/ethnicity (reference: non-Hispanic white) 
 Non-Hispanic Black 0.16 –0.33, +0.66 
 Non- Hispanic other 0.36 –0.03, +0.74 
 Hispanic 0.37 a 0.02, +0.72 
Income (in dollars) (reference: <$30,000) 
 $30–60,000 –0.36 a –0.69, -0.03 
 $60–100,000 –0.03 –0.35, +0.29 
 >$100,000 –0.23 –0.62, +0.19 
Previous research participation –0.32 –0.74, +0.09 
Distance to travel for participation (reference: < 15 min) 
 15–30 minutes –0.12 –0.44, +0.20 
 31–60 minutes –0.48 a –0.89, +0.06 
 >60 minutes 0.05 –0.50, +0.59 
 Unsure –0.22 –0.56, +0.11 
Importance of time (reference: very important) 
 Somewhat important –0.14 –0.52, +0.24 
 Not important –0.29 –0.99, +0.42 
Importance of pain/discomfort (reference: very important) 
 Somewhat important 0.48 –0.31, +0.40 
 Not important –0.07 –0.80, +0.65 
Importance of risk (reference: very important) 
 Somewhat important –0.30 –0.73, +0.13 
 Not important –0.36 –1.40, +0.68 
Importance of payment (reference: very important) 
 Somewhat important –0.04 –0.43, +0.35 
 Not important –0.28 –0.83, +0.30 
Importance of benefi t to self (reference: very important) 
 Somewhat important –0.27 –0.66, +0.13 
 Not important 0.38 –0.48, +1.23 
Importance of benefi t to others (reference: very important) 
 Somewhat important 0.08 –0.25, +0.42 
 Not important 0.94 a 0.13, +1.86 
 Requested compensation fi gures were log transformed in analysis. 
a p ≤ 0.05. 
 Table 3.  Association between requested payment for research participation (log transformed), sociodemographic characteristics and the importance of different factors 
affecting willingness to participate in clinical research. 
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of hypothetical payment (Figure  2 ), we again found that higher 
payment would be expected to yield not only higher likelihood 
of perceiving payment as fair, but closer population-level 
proportional representation of each of the four income groups. 
However, the diﬀ erences in perception of 
fairness versus Census distribution were not 
as large as for diﬀ erent racial/ethnic groups. 
 Discussion 
 Th is is the ﬁ rst study to examine a nationally 
representative sample to evaluate whether 
the amount of payment provided for clinical 
research may disproportionately affect 
recruitment of minorities and the lowest 
income group due to varied expectations 
about fair payment for participation in low-
risk clinical research. We found that racial/
ethnic minorities in general, and Hispanics in 
particular, request higher payment than non-
Hispanic whites to participate in research 
with the same description of risk and beneﬁ t. 
While there were diﬀ erences between the 
medians versus the means for whether non-
Hispanic blacks wanted more compensation 
than non-Hispanic whites, the median requested income was the 
same for both blacks who were willing to participate and those who 
were unsure if they would participate, both of which were similar 
to requested payment by whites. Th is suggests that, contrary to 
 Median requested  payment 
(interquartile range) 
Mean requested  payment 
(SD) 
Income 
 <$30,000 400 (900) 1,252 (2,304) 
 $30–60,000 300 (500) 1,064 (2,081) 
 $60–100,000 400 (900) 1,077 (2,086) 
 >$100,000 300 (500) 1,097 (2,274) 
Race/ethnicity 
 Non-Hispanic white 300 (500) 989 (2,008) 
 Non-Hispanic black 300 (1,100) 1,537 (2,813) 
 Non-Hispanic other 500 (700) 1,516 (2,689) 
 Hispanic 500 (900) 1,474 (2,241) 
 Table 4.  Unadjusted median and mean requested payment in those unsure or willing to participate in research 
by income and race/ethnicity. 
 Figure 1.  Relative proportion of racial/ethnic groups at different payment levels for participation in a hypothetical study. 
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conventional wisdom, members of racial/ethnic minority groups 
may not be more likely to participate than whites at lower levels 
of payment. Moreover, these ﬁ ndings may provide new insight 
about why racial/ethnic minorities (particularly Hispanics) are 
underrepresented in clinical trials. Furthermore, we found that 
low-income subjects did not, in general, demand lower levels of 
payment for participation, oﬀ ering evidence that they may not be 
unduly inﬂ uenced by payment to participate in research. 
 Th is study addresses a key knowledge gap related to public 
participation in medical research, which is currently insuﬃ  cient to 
meet enrollment goals for one-third of studies. 11 At present, there 
is no consensus regarding what constitutes appropriate or fair 
payment for clinical research participation, and most IRBs do not 
have written guidelines for determining how to pay participants. 16,23 
A majority of IRB members are concerned that any payment may 
be coercive or unduly inﬂ uential of potential research participants, 
with increasing concern for higher payments used as incentives or 
as payment for risk. 15  While there is no research to date about how 
IRB members’ perceptions may inﬂ uence approval of protocols, it 
is conceivable that pervasive beliefs about undue inﬂ uence may 
ultimately discourage investigators from oﬀ ering payments to 
participants that would be perceived to be incentives or payment 
for risk by IRBs. 
 Members of IRBs demonstrate the broadest support 
for reimbursement of expenses or payment for time and 
inconvenience. 15 However, most protocols do not indicate how 
much each clinic visit or hospitalization is compensated, and wide 
variation in payment exists for relatively comparable studies. 23 For 
Phase III clinical trials, similar to the hypothetical scenario in this 
study, Grady found that the median payment for such studies was 
$275 with a mean of $361. 23 For studies that enrolled both healthy 
volunteers and patients, the median payment was $100 with a 
mean of $199. 23 Th ese mean payment values fall substantively 
below payment requested by Hispanic and the lowest income 
group respondents in our sample, even when accounting for 
inﬂ ation. 
 Underenrollment and inequitable enrollment 
 Consequently, ﬁ ndings from this nationally representative sample 
raise the concern that underenrollment in clinical research may 
be explained in part by the public’s perception that payment is 
less than fair. While there were a few respondents who are willing 
to participate without payment, the majority of respondents 
requested payment at levels higher than what Grady found in her 
national study for more invasive and time-consuming studies of 
similar risk. Th e median requested payments were approximately 
 Figure 2.  Relative proportion of income groups at different payment levels for participation in a hypothetical study. 
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one-third the mean requested payments in our ﬁ ndings, and are 
closer to Grady’s reported values, but in the Hispanic subgroup 
in particular the requests are still twice the median reported by 
Grady for trials that are likely more invasive than our hypothetical 
case. Our findings suggest that increasing subject payment 
may mitigate problems of underenrollment while potentially 
increasing trial costs. However, the increase in trial costs due to the 
costs of higher payment may be oﬀ set by shortening enrollment 
periods and thereby decreasing operating costs. 
 Concerns that the poor are overrepresented in clinical 
research and that they are more susceptible to undue inﬂ uence 
from ﬁ nancial payments for participation 14 are called into question 
by this study and warrant further investigation. While there are 
few data regarding participation of the poor in research because 
many protocols do not routinely collect socioeconomic data on 
participants, our study oﬀ ers two key insights on this issue. First, 
in examining the income distribution of study respondents who 
stated they had previously participated in research, the lowest 
income group is not disproportionately represented. Second, 
our data demonstrate that payment requests do not decrease 
monotonically with income. In fact, when presented with exactly 
the same description of a scientiﬁ c research opportunity, the 
lowest income subgroup did not request a signiﬁ cantly diﬀ erent 
payment than the highest income subgroup. While these ﬁ ndings 
do not demonstrate unequivocally that the lowest income group is 
not inﬂ uenced by payment, they do suggest that the low levels of 
payment for clinical research currently oﬀ ered across the nation 
do not preferentially lead the lowest income group to participate. 
 Regarding research payment and minority enrollment, 
Hispanics (who have participated signiﬁ cantly less than non-
Hispanic whites in clinical research) request a signiﬁ cantly higher 
payment than non-Hispanic whites. While language barriers may 
contribute to the underenrollment of Hispanics in general in the 
United States, 24 our survey was only administered in English and 
all Hispanic respondents considered themselves ﬂ uent in English, 
mitigating the possibility that language proﬁ ciency was driving the 
request for higher payment in this study. Alternatively, Hispanics’ 
higher request for payment may correspond with concerns about 
their trust in the system—a barrier to participation believed to 
be held by African Americans. 25 Importantly, non-Hispanic 
black respondents in this study did not request signiﬁ cantly 
higher payment for participation than non-Hispanic whites, 
suggesting that payment may not be the only factor driving 
blacks’ underenrollment that mirrors that of Hispanics at the 
national level. Further research is warranted regarding other 
factors that may inﬂ uence disparities in research participation 
for communities of color, including access to health care that is 
known to diﬀ er substantially by race/ethnicity 26 and may aﬀ ect 
how patients of color learn about research opportunities. 
 Our analysis of how proportional participation may vary 
with oﬀ ered payment further illuminates the potential eﬀ ects of 
IRB judgments about fair and noncoercive treatment for subjects. 
At payment levels below the median requested payment for the 
hypothetical trial described in this study, non-Hispanic blacks and 
Hispanics are underrepresented with respect to their population 
composition. In contrast, proportional representation was more 
consistent for diﬀ erent income groups across the spectrum of 
payment levels. Given that the lowest and highest income groups 
believe similar payment levels are fair and racial/ethnic minorities 
believe higher payment is warranted to be fair, higher levels of 
payment may be a key to reducing minority underenrollment 
in clinical research and may not be unduly inﬂ uential. Given 
the statistically signiﬁ cant association of increased requested 
payment with “importance of beneﬁ t to others,” there is an 
imperative to examine in greater detail how and why distinct 
racial/ethnic groups and income groups diﬀ er with regard to 
their consideration of participation in medical research. While 
not addressed in this paper, other analyses are ongoing regarding 
the nature and dynamics of diﬀ erences by race/ethnicity with 
respect to other sociodemographic factors. 
 Limitations 
 Limitations to this study must be acknowledged. First, the 
hypothetical scenario addresses only one type of research study, 
which many not be generalizable to other types of clinical 
research circumstances. Particularly if participants were asked 
to participate as a healthy volunteer, higher risk studies may 
produce diﬀ erent requests for payment. Second, those who have 
participated or been recruited to participate in clinical research 
may have their requested payment inﬂ uenced by previous oﬀ ers 
for payment which anchored their expectations and lowered their 
requested amount. Th ird, perceptions about fair payment do not 
necessarily track with one’s willingness to participate in research, 
however, the variation across diﬀ erent racial/ethnic and income 
groups tracks with enrollment and therefore should be considered 
as a factor in willingness to participate in research. Additionally, 
potential subjects may be willing to accept payment at levels lower 
than what they perceive to be fair. 
 Fourth, the survey provides respondents’ stated preferences 
instead of observations of actual behavior when confronted with 
alternative payments. Further research that randomly varies 
payment would provide valuable data about whether individuals 
vary their willingness to participate in research, and whether this 
varies by racial/ethnic groups. Such research would be helpful in 
determining whether increased payment may reduce observed 
disparity in enrollment and whether and how it aﬀ ects individuals’ 
perceptions of risk. Finally, the sample comes from a panel of 
potential subjects who have agreed to respond to surveys, which 
could theoretically make the group self-selected. 
 Conclusion 
 Our data is consistent with other studies that demonstrate that 
minorities have participated in medical research at lower rates 
than non-Hispanic whites 4,5 but adds evidence that low-income 
individuals are not disproportionately represented in medical 
research overall. Our ﬁ nding that low-income individuals request 
payment for participation similar to high-income peers also 
mitigates the theoretical concern that the lowest income group 
is particularly susceptible to payment for participation. While 
proportional representation by socioeconomic status is achievable 
at payment levels similar to what is typically oﬀ ered, our data 
indicate that higher payment may be necessary to increase 
Hispanics’ participation in research and to achieve higher public 
participation in research overall. If the research community 
is committed to achieving adequate representation in clinical 
research to identify treatments that work in racial/ethnic minority 
populations, investigators will likely need to oﬀ er what these 
groups consider fair payments for participation. 
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 Appendix 
 Figure A1. Survey item for requested payment for clinical research participation. 
